News

March 2, 2016March 2, 2016

FDA Approves Once-Daily Rheumatoid Arthritis Oral Drug, Xeljanz XR, by Pfizer

News

Pfizer, Inc., recently announced that the U.S. Food and Drug Administration (FDA) has approved Xeljanz XR (tofacitinib citrate) extended-release 11 mg tablets as a once-daily treatment of patients with moderate to severe ... Read more

February 29, 2016February 29, 2016

Rheumatoid Arthritis Not Seen to Raise Person’s Risk of Cardiovascular Complications Due to Surgery

News

Patients with rheumatoid arthritis (RA) have a high overall incidence of mortality, primarily due to cardiovascular complications. But RA patients are not at increased risk for post-surgery cardiovascular complications or death compared ... Read more

February 26, 2016February 26, 2016

Newly Discovered Nanomedicines Offer Novel and Promising Approach to RA and Autoimmune Disease Treatment

News, rheumatoid arthritis

New research from the University of Calgary might change our current understanding and ways of treating a range of autoimmune diseases, from rheumatoid arthritis to type 1 diabetes and multiple sclerosis. ... Read more

February 24, 2016May 23, 2016

Potential RA Treatment, a Biosimilar to Infliximab, Acquired by Sandoz for Development in Europe

News

Sandoz, a Novartis company focused on generic pharmaceuticals, announced it has acquired the rights to Pfizer’s biosimilar to infliximab (PF-06438179) in the European Economic Area (EEA) as a possible treatment for autoimmune diseases ... Read more

February 17, 2016February 17, 2016

Serious RA Infections May Be Linked to Opioid Use, Study Reports

News

Researchers at Vanderbilt University Medical Center report that the use of opioid analgesics by patients with rheumatoid arthritis may increase their likelihood of serious infection and subsequent hospitalization. Their study, “Opioid Analgesics and ... Read more

February 15, 2016May 23, 2016

AbbVie Invites Rheumatoid Arthritis Students to Apply for $15,000 Scholarships

News

AbbVie has started a new scholarship program to help outstanding students with rheumatologic diseases, such as rheumatoid arthritis (RA), pursue higher education. A total of 15 scholarships, each worth $15,000, are available for ... Read more

February 12, 2016February 12, 2016

More than $3.7 Million in RA Research Funded by Arthritis Foundation Scientific Discovery Awards

News

The Arthritis Foundation announced the 11 foundation’s 2015 Scientific Discovery Awards for their innovative research in arthritis and related diseases. This was the foundation’s first request for proposals (RFP), with revised eligibility criteria so that ... Read more

February 10, 2016February 10, 2016

African-Americans with Rheumatoid Arthritis and Like Diseases at Cardiovascular Risk

News

Research conducted into the medical records of over a quarter million adults found that African-Americans with connective tissue diseases such as rheumatoid arthritis are twice as likely as whites with these diseases to suffer complications that increase ... Read more

February 8, 2016February 8, 2016

Potential Rheumatoid Arthritis Therapy Seen in a Naturally Produced Protein Called TTP

News

Increasing the levels of tristetraprolin (TTP), a protein naturally produced in the body, helped to reduce or protect mice against inflammation, a study found, suggesting that pharmaceutical compounds capable of ... Read more

February 5, 2016February 5, 2016

Rheumatoid Arthritis Treatment with TNF Inhibitors May Raise Cervical Dysplasia Risk

News

A Swedish nationwide study in women with rheumatoid arthritis (RA) found an elevated risk for cervical dysplasia in those treated with tumor necrosis factor (TNF) inhibitors, a common RA therapy. The ... Read more